Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related Treatments
K. Robin Yabroff, Jingxuan Zhao, Janet S. de Moor, et al.
JNCI Journal of the National Cancer Institute (2019) Vol. 112, Iss. 5, pp. 498-506
Open Access | Times Cited: 25

Showing 25 citing articles:

Importance of Patient Health Insurance Coverage and Out-of-Pocket Costs for Genomic Testing in Oncologists' Treatment Decisions
K. Robin Yabroff, Kewei Sylvia Shi, Jingxuan Zhao, et al.
JCO Oncology Practice (2024) Vol. 20, Iss. 3, pp. 429-437
Closed Access | Times Cited: 6
Understanding communication between patients and healthcare professionals regarding comprehensive biomarker testing in precision oncology: A scoping review
Theresia Pichler, Friederike Mumm, Navdeep Dehar, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 6
Disparities in germline testing among racial minorities with prostate cancer
Nicole Weise, Justin Shaya, Juan Javier‐Desloges, et al.
Prostate Cancer and Prostatic Diseases (2021) Vol. 25, Iss. 3, pp. 403-410
Open Access | Times Cited: 35
Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans
Yonghong Li, Avneet K. Heer, Hillary S. Sloane, et al.
JAMA Health Forum (2024) Vol. 5, Iss. 5, pp. e241270-e241270
Open Access | Times Cited: 5
Racial and ethnic disparities in genomic testing among lung cancer patients: a systematic review
Clare Meernik, Yadurshini Raveendran, Michala Kolarova, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 6, pp. 812-828
Closed Access | Times Cited: 4
Distribution of Genomic Testing Resources by Oncology Practice and Rurality: A Nationally Representative Study
Brittany Gardner, Michelle Doose, Janeth I. Sanchez, et al.
JCO Precision Oncology (2021), Iss. 5, pp. 1060-1068
Open Access | Times Cited: 23
Perspectives on Conversations About Costs of Cancer Care of Breast Cancer Survivors and Cancer Center Staff
Maria Pisu, Yu‐Mei Schoenberger, Ivan Herbey, et al.
Annals of Internal Medicine (2019) Vol. 170, Iss. 9_Supplement, pp. S54-S54
Closed Access | Times Cited: 25
Radiomics Predicts for Distant Metastasis in Locally Advanced Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
Benjamin Rich, Jianfeng Huang, Yidong Yang, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5689-5689
Open Access | Times Cited: 20
Financial toxicity in lung cancer
M. Boulanger, Carley Mitchell, Jeffrey Zhong, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care
Christine M. Gunn, Emma X. Li, Gretchen A. Gignac, et al.
Cancer Control (2023) Vol. 30
Open Access | Times Cited: 7
Opinions and strategies of Australian health professionals on tackling cancer‐related financial toxicity: A nationwide survey
Louisa G. Gordon, Dorean Nabukalu, Raymond J. Chan, et al.
Asia-Pacific Journal of Clinical Oncology (2022) Vol. 19, Iss. 1, pp. 126-135
Closed Access | Times Cited: 10
Clinical and cost outcomes following genomics‐informed treatment for advanced cancers
Deirdre Weymann, Samantha Pollard, Brandon Chan, et al.
Cancer Medicine (2021) Vol. 10, Iss. 15, pp. 5131-5140
Open Access | Times Cited: 13
Urban-Rural and Socioeconomic Differences in Patient Knowledge and Perceptions of Genomic Tumor Testing
Jessica F. DiBiase, Elizabeth Scharnetzki, Emily Edelman, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 5
Development and validation of a deep learning radiomics model with clinical-radiological characteristics for the identification of occult peritoneal metastases in patients with pancreatic ductal adenocarcinoma
Siya Shi, Chuxuan Lin, Jian Zhou, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 1
Cost‐of‐care discussions for individuals with advanced non–small cell lung cancer and melanoma: Findings from a large, population‐based pilot study
K. Robin Yabroff, Karen Mittu, Michael T. Halpern
Cancer (2024) Vol. 130, Iss. 19, pp. 3364-3374
Closed Access | Times Cited: 1
Co-morbid risk factors and NSAID use among white and black Americans that predicts overall survival from diagnosed colon cancer
Minoru Koi, Yoshiki Okita, Koki Takeda, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0239676-e0239676
Open Access | Times Cited: 8
Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016)
Macy Goldbach, Laura Burkbauer, Tina Bharani, et al.
Annals of Surgical Oncology (2021) Vol. 28, Iss. 13, pp. 8651-8662
Open Access | Times Cited: 7
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients
Lourdes Mengual, Maria Frantzi, Marika Mokou, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 11, pp. 2043-2051
Open Access | Times Cited: 4
Toward a More Just System of Care in Molecular Pathology
Cullen M. Lilley, MINERVE DELILLE, Kamran Mirza, et al.
Milbank Quarterly (2022) Vol. 100, Iss. 4, pp. 1192-1242
Open Access | Times Cited: 3
A video intervention to improve patient understanding of tumor genomic testing in patients with cancer
Deloris Veney, Lai Y. Wei, Amanda Ewart Toland, et al.
Cancer Medicine (2024) Vol. 13, Iss. 17
Open Access
A History of Health Economics and Healthcare Delivery Research at the National Cancer Institute
V. Paul Doria‐Rose, Nancy Breen, Martin L. Brown, et al.
JNCI Monographs (2022) Vol. 2022, Iss. 59, pp. 21-27
Open Access | Times Cited: 2
Patient Understanding of Tumor Genomic Testing: A Quality Improvement Effort
Leigha Senter, Deloris Veney, Taylor Surplus, et al.
JCO Oncology Practice (2022) Vol. 19, Iss. 1, pp. e8-e14
Open Access | Times Cited: 2
Talking the Talk About Tumor Genomic Testing
Richard L. Schilsky
JNCI Journal of the National Cancer Institute (2019) Vol. 112, Iss. 5, pp. 436-437
Open Access | Times Cited: 1
Emerging Biomarkers: Innovative Therapies for Rare Disease
Joseph Kim
Oncology Issues (2023) Vol. 38, Iss. 4, pp. 76-80
Closed Access
Cost discussions on genomic testing in cancer patients

PharmacoEconomics & Outcomes News (2019) Vol. 841, Iss. 1, pp. 8-8
Closed Access
Page 1

Scroll to top